Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Cash: 2009-2024

Historic Change in Cash for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to -$472000.0.

  • OptimizeRx's Change in Cash rose 15141.39% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 15929.42%. This contributed to the annual value of -$472000.0 for FY2024, which is 8916.69% up from last year.
  • Per OptimizeRx's latest filing, its Change in Cash stood at -$472000.0 for FY2024, which was up 8916.69% from -$4.4 million recorded in FY2023.
  • OptimizeRx's Change in Cash's 5-year high stood at $74.2 million during FY2021, with a 5-year trough of -$66.5 million in FY2022.
  • In the last 5 years, OptimizeRx's Change in Cash had a median value of -$4.4 million in 2023 and averaged -$1.1 million.
  • Per our database at Business Quant, OptimizeRx's Change in Cash soared by 98970.55% in 2021 and then plummeted by 18962.87% in 2022.
  • OptimizeRx's Change in Cash (Annual) stood at -$8.3 million in 2020, then skyrocketed by 989.71% to $74.2 million in 2021, then plummeted by 189.63% to -$66.5 million in 2022, then skyrocketed by 93.45% to -$4.4 million in 2023, then skyrocketed by 89.17% to -$472000.0 in 2024.
  • Its last three reported values are -$472000.0 in FY2024, -$4.4 million for FY2023, and -$66.5 million during FY2022.